image

The best stocks to buy since 1993

Our latest issue will be released in 13 days, don't miss out!

Majestic Wine

February 2003

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • WINE
The story at Majestic is one of strong organic growth. This month's update of Christmas trading is pretty impressive with like-for-like sales up 10.8% in the eight weeks of Christmas trading to 31 December. This is being driven by a growing number of customers  on the mailing list which stands at 291,000 active names, up 10.2% from this time last year.There continues to be further improvement in margins. Teather & Greenwood has upgraded to 35.1p for the year just ended, with 38.5p in the current year.The shares remain a buy.  ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe